Intrinsiqs

Is Ionis Pharmaceuticals, Inc. overvalued?

Ionis Pharmaceuticals, Inc. (IONS) — key valuation metrics and fundamentals.

No verdict
Price
$44.50
Fair value
—
Current P/E
—
Normal P/E
26.1
Market cap
$7.40B
Dividend yield
0.0%
Return on equity
-110.8%
Sector
Healthcare

See the full interactive analysis →

Fair value compares IONS's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.